Short-term efficacy and toxicity of total neoadjuvant chemotherapy in patients with resectable gastric cancer
Background. Currently, perioperative chemotherapy is the standard treatment option for resectable gastric cancer (GC ) at stages higher than T1. Preoperative chemotherapy was shown do not adversely affect the course of the postoperative period in gastric cancer patients. However, approximately 60 %...
Saved in:
| Main Authors: | A. V. Avgustinovich, S. G. Afanasyev, A. Yu. Dobrodeev, M. Yu. Volkov, D. N. Kostromitsky, L. V. Spirina, O. V. Cheremisina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2022-03-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/2023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immediate results of neoadjuvant chemotherapy for resectable colon cancer
by: D. I. Azovsky, et al.
Published: (2025-03-01) -
Efficacy and safety of neoadjuvant treatment with chemotherapy and immune checkpoint blockades for potentially resectable gastric cancer: A retrospective study
by: Huiyun Wang, et al.
Published: (2025-12-01) -
ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01) -
CT-based quantification of spatiotemporal heterogeneity for predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer
by: Wenjun Hu, et al.
Published: (2025-07-01) -
Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01)